As filed with the Securities and Exchange Commission on May 5, 2015.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
HEALTHEQUITY, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
7389 (Primary Standard Industrial Classification Code Number) |
52-2383166 (I.R.S. Employer Identification Number) |
15 W. Scenic Pointe Dr.
Ste. 100
Draper, Utah 84020
(801) 727-1000
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
JON KESSLER
President and Chief Executive Officer
15 W. Scenic Pointe Dr.
Ste. 100
Draper, Utah 84020
(801) 727-1000
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to: | ||
GORDON R. CAPLAN, Esq. JEFFREY S. HOCHMAN, Esq. Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, New York 10019 (212) 728-8000 |
CHARLES S. KIM, Esq. ANDREW S. WILLIAMSON, Esq. DAVID G. PEINSIPP, Esq. Cooley LLP 4401 Eastgate Mall San Diego, California 92121 (858) 550-6000 |
Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date hereof.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ý 333-203190.
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o | Accelerated filer o | Non-accelerated filer ý (Do not check if a smaller reporting company) |
Smaller reporting company o |
CALCULATION OF REGISTRATION FEE
|
||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered(1) |
Proposed Maximum Offering Price Per Share |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee(2) |
||||
---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 par value per share |
287,500 | $25.90 | $7,446,250 | $866 | ||||
|
The Registration Statement shall become effective upon filing in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.
EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
This Registration Statement is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the "Securities Act"), for the purpose of registering additional shares of common stock, par value $0.0001 per share. The contents of the Registration Statement on Form S-1, as amended (File No. 333-203190) (the "Initial Registration Statement"), filed by HealthEquity, Inc. with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Act, which was declared effective by the Commission on May 5 , 2015, are incorporated by reference into this Registration Statement.
The Registrant hereby certifies to the Commission that (i) it has instructed its attorneys to pay on its behalf to the Commission the filing fee set forth on the cover page of this Registration Statement by a wire transfer of such amount to the Securities and Exchange Commission's account at U.S. Bank as soon as practicable (but no later than the close of business on May 6, 2015), (ii) it will not revoke such instructions, (iii) there are sufficient funds in the relevant account to cover the amount of such filing fee, and (iv) it will confirm receipt of such instructions no later than May 6, 2015.
The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 16. Exhibits and Financial Statement Schedules.
(a) Exhibits. All exhibits previously filed or incorporated by reference in the Initial Registration Statement are incorporated by reference into, and shall be deemed to be a part of this filing, except for the following, which are filed herewith:
Exhibit No. | Description of Exhibit | |
---|---|---|
5.1 |
Opinion of Willkie Farr & Gallagher LLP | |
23.1 |
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm |
|
23.2 |
Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1) |
|
24.1 |
Power of Attorney (included on the signature page to the Initial Registration Statement and incorporated by reference herein) |
II-1
Signatures
Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Draper, State of Utah on this 5th day of May, 2015.
HEALTHEQUITY, INC. | ||||
By: |
/s/ JON KESSLER |
|||
Name: | Jon Kessler | |||
Title: | President and Chief Executive Officer |
II-2
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
---|---|---|---|---|
/s/ JON KESSLER Jon Kessler |
President, Chief Executive Officer and Director (Principal Executive Officer) |
May 5, 2015 | ||
/s/ DARCY MOTT Darcy Mott |
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
May 5, 2015 |
||
* Stephen D. Neeleman, M.D. |
Director |
May 5, 2015 |
||
* Frank T. Medici |
Director |
May 5, 2015 |
||
* Ian Sacks |
Director |
May 5, 2015 |
||
* Frank A. Corvino |
Director |
May 5, 2015 |
||
* Michael O. Leavitt |
Director |
May 5, 2015 |
||
* Manu Rana |
Director |
May 5, 2015 |
||
* Evelyn Dilsaver |
Director |
May 5, 2015 |
By: | /s/ JON KESSLER Jon Kessler Attorney-in-Fact |
II-3